AtaiBeckley (ATAI) Cash from Financing Activities (2020 - 2026)

AtaiBeckley's quarterly Cash from Financing Activities came in at $821000.0 in Q1 2026, down 98.62% year-on-year from $59.6 million in Q1 2025, and down 98.62% quarter-over-quarter from $59.6 million in Q1 2025.

AtaiBeckley's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $59.7 million for Q3 2025.

  • In Q3 2025, Cash from Financing Activities rose 1120.76% year-over-year to $59.7 million; the TTM figure through Sep 2025 stood at $127.3 million (up 4026.57% YoY), while the FY2024 annual figure was $5.4 million, up 164.32% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $821000.0, down from $59.6 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $59.6 million in Q1 2025, with the low at $821000.0 in Q1 2026.
  • A 5-year average of $32.6 million and a median of $1.8 million in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities tumbled 817.68% in 2023 and soared 2279.45% in 2025, its largest moves.
  • AtaiBeckley's Cash from Financing Activities stood at $1.7 million in 2021, then tumbled by 153.51% to -$922000.0 in 2022, then sank by 817.68% to -$8.5 million in 2023, then surged by 101.82% to $154000.0 in 2024, then jumped by 38694.81% to $59.7 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $59.7 million, $7.8 million, and $59.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 7.00 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 53,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 15.71 Mn
10 AtaiBeckley 1.62 Bn 1.62 Bn - 821,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 821,000.00
Mar 31, 2026 821,000.00
Sep 30, 2025 59.74 Mn
Sep 30, 2025 59.74 Mn
Jun 30, 2025 7.76 Mn
Jun 30, 2025 7.76 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Dec 31, 2024 154,000.00
Dec 31, 2024 154,000.00
Sep 30, 2024 4.89 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 326,000.00
Jun 30, 2024 326,000.00
Dec 31, 2023 -8.46 Mn
Dec 31, 2023 -8.46 Mn
Jun 30, 2023 -100,000.00
Jun 30, 2023 -100,000.00
Mar 31, 2023 206,000.00
Mar 31, 2023 206,000.00
Dec 31, 2022 -922,000.00
Dec 31, 2022 -922,000.00
Sep 30, 2022 19.78 Mn
Sep 30, 2022 19.78 Mn
Jun 30, 2022 1.79 Mn
Jun 30, 2022 1.79 Mn
Mar 31, 2022 132,000.00
Mar 31, 2022 132,000.00
Dec 31, 2021 1.72 Mn
Dec 31, 2021 1.72 Mn
Sep 30, 2021 3.88 Mn
Sep 30, 2021 3.88 Mn
Jun 30, 2021 373.76 Mn
Jun 30, 2021 373.76 Mn
Mar 31, 2021 30.50 Mn
Mar 31, 2021 30.50 Mn
Dec 31, 2020 81.98 Mn
Dec 31, 2020 81.98 Mn
Sep 30, 2020 18.06 Mn
Sep 30, 2020 18.06 Mn